다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Oxidative medicine and cellular longevity, v.2017, 2017년, pp.6792543 -
Lin, Jiajia (Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China) , Yu, Jie (Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China) , Zhao, Jiaying (Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Ningbo University, Ningbo 315211, China) , Zhang, Ke (Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China) , Zheng, Jiachen (Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China) , Wang, Jialing (Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China) , Huang, Chunhui (Li Dak Sum Yip Yio Chin Kenneth Li Marine Biop) , Zhang, Jingrong , Yan, Xiaojun , Gerwick, William H. , Wang, Qinwen , Cui, Wei , He, Shan
AI-Helper
Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized by neurofibrillary tangles, synaptic impairments, and loss of neurons. Oligomers of β-amyloid (Aβ) are widely accepted as the main neurotoxins to induce oxidative stress and neuronal loss in AD. In this ...
1 Scheltens P. Blennow K. Breteler M. M. Alzheimer’s disease Lancet 2016 388 10043 505 517 10.1016/S0140-6736(15)01124-1 2-s2.0-84989162422 26921134
2 Klein W. L. Synaptotoxic amyloid-beta oligomer: a molecular basis for the cause, diagnosis, and treatment of Alzheimer’s disease? Journal of Alzheimer’s Disease 2013 33 Supplement 1 S49 S65 10.3233/JAD-2012-129039 2-s2.0-84872552899
3 Ferreira S. T. Klein W. L. The A β oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease Neurobiology of Learning and Memory 2011 96 529 543 10.1016/j.nlm.2011.08.003 2-s2.0-82355192272 21914486
4 Jimenez S. Torres M. Vizuete M. Age-dependent accumulation of soluble amyloid beta (Abeta) oligomer reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model The Journal of Biological Chemistry 2011 286 18414 18425 10.1074/jbc.M110.209718 2-s2.0-79956320988 21460223
5 Chong Y. H. Shin Y. J. Lee E. O. Kayed R. Glabe C. G. Tenner A. J. ERK1/2 activation mediates A β oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures The Journal of Biological Chemistry 2006 281 20315 20325 10.1074/jbc.M601016200 2-s2.0-33745985711 16714296
6 Kim B. Park J. Chang K. T. Lee D. S. Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal cell death by inhibiting ERK-Drp1-mediated mitochondrial fragmentation Free Radical Biology and Medicine 2016 90 184 194 10.1016/j.freeradbiomed.2015.11.015 2-s2.0-84948808875 26582373
7 Gammone M. A. Riccioni G. D'Orazio N. Marine carotenoids against oxidative stress: effects on human health Marine Drugs 2015 13 6226 6246 10.3390/md13106226 2-s2.0-84945915143 26437420
8 Gammone M. A. D'Orazio N. Anti-obesity activity of the marine carotenoid fucoxanthin Marine Drugs 2015 13 2196 2214 10.3390/md13042196 2-s2.0-84928411843 25871295
9 Lin J. Huang L. Yu J. Fucoxanthin, a marine carotenoid, reverses scopolamine-induced cognitive impairments in mice and inhibits acetylcholinesterase in vitro Marine Drugs 2016 14 10.3390/md14040067 2-s2.0-84962626467
10 Pangestuti R. Vo T. S. Ngo D. H. Kim S. K. Fucoxanthin ameliorates inflammation and oxidative reponses in microglia Journal of Agricultural and Food Chemistry 2013 61 3876 3883 10.1021/jf400015k 2-s2.0-84876739288 23551304
11 Zhao X. Zhang S. An C. Neuroprotective effect of fucoxanthin on β -amyloid-induced cell death Journal of Chinese Pharmaceutical Sciences 2015 24 467 474 10.5246/jcps.2015.07.060 2-s2.0-84939634040
12 Jung H. A. Ali M. Y. Choi R. J. Jeong H. O. Chung H. Y. Choi J. S. Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera Food and Chemical Toxicology 2016 89 104 111 10.1016/j.fct.2016.01.014 2-s2.0-84956637838 26825629
13 Jiang L. Huang M. Xu S. Bis(propyl)-cognitin prevents beta-amyloid-induced memory deficits as well as synaptic formation and plasticity impairments via the activation of PI3-K pathway Molecular Neurobiology 2016 53 3832 3841 10.1007/s12035-015-9317-9 2-s2.0-84978154336 26160762
14 Wang Q. Rowan M. J. Anwyl R. Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide The Journal of Neuroscience 2004 24 6049 6056 10.1523/JNEUROSCI.0233-04.2004 2-s2.0-3042798841 15240796
15 Cui W. Zhang Z. Li W. The anti-cancer agent SU4312 unexpectedly protects against MPP + -induced neurotoxicity via selective and direct inhibition of neuronal NOS British Journal of Pharmacology 2013 168 1201 1214 10.1111/bph.12004 2-s2.0-84874225372 23062100
16 Cui W. Zhang Z. J. Hu S. Q. Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction CNS Neuroscience & Therapeutics 2014 20 244 252 10.1111/cns.12203 2-s2.0-84894236810 24393200
17 Yu J. Zheng J. Lin J. Indirubin-3-oxime prevents H 2 O 2 -induced neuronal apoptosis via concurrently inhibiting GSK3β and the ERK pathway Cellular and Molecular Neurobiology 2017 37 4 655 664 10.1007/s10571-016-0402-z 2-s2.0-84978085795 27412761
18 Cui W. Zhang Z. Li W. Unexpected neuronal protection of SU5416 against 1-methyl-4-phenylpyridinium ion-induced toxicity via inhibiting neuronal nitric oxide synthase PLoS One 2012 7, article e46253 10.1371/journal.pone.0046253 2-s2.0-84866666308
19 Hu S. Wang R. Cui W. Inhibiting beta-amyloid-associated Alzheimer’s pathogenesis in vitro and in vivo by a multifunctional dimeric bis(12)-hupyridone derived from its natural analogue Journal of Molecular Neuroscience 2015 55 4 1014 1021 10.1007/s12031-014-0458-5 2-s2.0-84925520139 25407821
20 Hu S. Cui W. Zhang Z. Indirubin-3-oxime effectively prevents 6OHDA-induced neurotoxicity in PC12 cells via activating MEF2D through the inhibition of GSK3beta Journal of Molecular Neuroscience 2015 57 561 570 10.1007/s12031-015-0638-y 2-s2.0-84947032178 26346600
21 Guo B. Zheng C. Cai W. Multifunction of chrysin in Parkinson’s model: anti-neuronal apoptosis, neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B Journal of Agricultural and Food Chemistry 2016 64 5324 5333 10.1021/acs.jafc.6b01707 2-s2.0-84978038889 27245668
22 Kayed R. Lasagna-Reeves C. A. Molecular mechanisms of amyloid oligomer toxicity Journal of Alzheimer’s Disease 2013 33 Supplement 1 S67 S78 10.3233/JAD-2012-129001 2-s2.0-84872559990
23 Ryan D. A. Narrow W. C. Federoff H. J. Bowers W. J. An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies Journal of Neuroscience Methods 2010 190 171 179 10.1016/j.jneumeth.2010.05.001 2-s2.0-77954215576 20452375
24 Wang Q. Walsh D. M. Rowan M. J. Selkoe D. J. Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 The Journal of Neuroscience 2004 24 3370 3378 10.1523/JNEUROSCI.1633-03.2004 2-s2.0-1842610852 15056716
25 Kim K. Park K. S. Kim M. K. Choo H. Chong Y. Dicyanovinyl-substituted J147 analogue inhibits oligomerization and fibrillation of beta-amyloid peptides and protects neuronal cells from beta-amyloid-induced cytotoxicity Organic & Biomolecular Chemistry 2015 13 9564 9569 10.1039/c5ob01463h 2-s2.0-84941905929 26303522
26 Cameron R. T. Quinn S. D. Cairns L. S. The phosphorylation of Hsp20 enhances its association with amyloid-beta to increase protection against neuronal cell death Molecular and Cellular Neurosciences 2014 61 46 55 10.1016/j.mcn.2014.05.002 2-s2.0-84902244714 24859569
27 Heo S. J. Jeon Y. J. Protective effect of fucoxanthin isolated from Sargassum siliquastrum on UV-B induced cell damage Journal of Photochemistry and Photobiology B 2009 95 101 107 10.1016/j.jphotobiol.2008.11.011 2-s2.0-64149125149
28 Pangestuti R. Kim S. K. Neuroprotective effects of marine algae Marine Drugs 2011 9 803 818 10.3390/md9050803 2-s2.0-79957648966 21673890
29 Kim K. N. Heo S. J. Yoon W. J. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-kappaB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages European Journal of Pharmacology 2010 649 369 375 10.1016/j.ejphar.2010.09.032 2-s2.0-78049236040 20868674
30 Choi J. H. Kim N. H. Kim S. J. Lee H. J. Kim S. Fucoxanthin inhibits the inflammation response in paw edema model through suppressing MAPKs, Akt, and NFkappaB Journal of Biochemical and Molecular Toxicology 2016 30 111 119 10.1002/jbt.21769 2-s2.0-84945948007 26418808
31 Zheng J. Piao M. J. Kim K. C. Yao C. W. Cha J. W. Hyun J. W. Fucoxanthin enhances the level of reduced glutathione via the Nrf2-mediated pathway in human keratinocytes Marine Drugs 2014 12 4214 4230 10.3390/md12074214 2-s2.0-84905833626 25028796
32 Finkel T. Holbrook N. J. Oxidants, oxidative stress and the biology of ageing Nature 2000 408 239 247 10.1038/35041687 2-s2.0-0034626735 11089981
33 Shi Z. M. Han Y. W. Han X. H. Upstream regulators and downstream effectors of NF-kappa B in Alzheimer’s disease Journal of the Neurological Sciences 2016 366 127 134 10.1016/j.jns.2016.05.022 2-s2.0-84969677272 27288790
34 Lin J. J. Huang L. Yu J. Fucoxanthin, a marine carotenoid, reverses scopolamine-induced cognitive impairments in mice and inhibits acetylcholinesterase in vitro Marine Drugs 2016 14 10.3390/md14040067 2-s2.0-84962626467
35 Parri H. R. Hernandez C. M. Dineley K. T. Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer’s disease Biochemical Pharmacology 2011 82 931 942 10.1016/j.bcp.2011.06.039 2-s2.0-80052033738 21763291
36 Nalivaeva N. N. Turner A. J. AChE and the amyloid precursor protein (APP) - cross-talk in Alzheimer’s disease Chemico-Biological Interactions 2016 259 301 306 10.1016/j.cbi.2016.04.009 2-s2.0-84963629039 27062894
37 Russo P. Del Bufalo A. Frustaci A. Fini M. Cesario A. Beyond acetylcholinesterase inhibitors for treating Alzheimer’s disease: alpha 7-nAChR agonists in human clinical trials Current Pharmaceutical Design 2014 20 6014 6021 10.2174/1381612820666140316130720 24641224
38 Wan-Loy C. Siew-Moi P. Marine algae as a potential source for anti-obesity agents Marine Drugs 2016 14 10.3390/md14120222 2-s2.0-85007454275
39 Abidov M. Ramazanov Z. Seifulla R. Grachev S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat Diabetes, Obesity & Metabolism 2010 12 72 81 10.1111/j.1463-1326.2009.01132.x 2-s2.0-73349138274
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.